Home » Insmed Selling Boulder Facility to Merck
Insmed Selling Boulder Facility to Merck
Insmed Inc. is selling its division focused on developing generic biotechnology drugs to pharmaceutical giant Merck for $130 million, the company announced.
Denver Business Journal
Denver Business Journal
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct